Miguel Fidalgo
A Coruna, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions.
Journal: Journal of cellular and molecular medicine
Published: March 02, 2026
GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing.
GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing.
Journal: Science immunology
Published: November 22, 2024
Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.
Journal: Molecular metabolism
Published: February 27, 2024
Induction of Transient Morula-Like Cells in Mice Through STAT3 Activation.
Journal: Cellular reprogramming
Published: February 01, 2024
Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway.
Journal: Hepatology (Baltimore, Md.)
Published: August 29, 2023
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.
Journal: Molecular metabolism
Published: May 24, 2023
Ferritin heavy chain supports stability and function of the regulatory T cell lineage.
Journal: The EMBO journal
Published: April 26, 2023
Reprogramming Stars #11: Teaming Up to Uncover the Epitranscriptomics of Reprogramming-An Interview with Dr. Miguel Fidalgo and Dr. Diana Guallar.
Journal: Cellular reprogramming
Published: April 13, 2023
Comparative functional genomics identifies unique molecular features of EPSCs.
Journal: Life science alliance
Published: July 15, 2022
Hepatic p63 regulates glucose metabolism by repressing SIRT1.
Journal: Gut
Published: November 22, 2021
A Simple, Rapid, and Cost-Effective Method for Loss-of-Function Assays in Pluripotent Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 06, 2021
Last Updated: 09/26/2026